Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers

Thalidomide, which inhibits angiogenesis in certain tumor types, reduced extravasation of a macromolecular contrast medium (MMCM) in a human breast cancer model as assayed by MMCM-enhanced dynamic magnetic resonance imaging (MRI) and fluorescence microscopy in the same tumors. After a 1-week, three-...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Eur Radiol
Prif Awduron: Cyran, Clemens C., Sennino, Barbara, Chaopathomkul, Bundit, Fu, Yanjun, Rogut, Victor S., Shames, David M., Wendland, Michael F., McDonald, Donald M., Brasch, Robert C.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2008
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5685658/
https://ncbi.nlm.nih.gov/pubmed/18665367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00330-008-1111-x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg